BACKGROUND OF THE INVENTION
Hyperforin is considered to be the constituent of St. John's Wort responsible for its antidepressant activity (see, e.g., Chatterjee et al., Life Sci. (1998) 63:499-510). Hyperforin is the only known selective agonist of TRPC6 (canonical transient receptor potential) ion
The present invention relates to the use of hyperforin as a cytostatic agent and to a hyperforin ointment or cream which is suitable as a form for applying the hyperforin.
Hyperforin and the hypericins are characteristic constituents of St. John's wort (Hypericum perforatum L.), which also contains
This application is a National Stage of International Application No. PCT/EP01/15281, filed Dec. 21, 2001.
The present invention relates to an improved and stable (i.e. colour-stable and, optionally, stable with regard to its hyperforin content) extract from the exposed parts of Hypericum perforatum
This application is a Rule 371 U.S. National Phase Filing of PCT/EP05/003657, filed Apr. 7, 2005, which, in turn, claims priority to European Patent Application No. 04.009213.2 filed Apr. 19, 2004, the contents of which are incorporated by reference herein in their entirety.
The present invention
اكتب أحد الأعراض أو المرض واقرأ عن الأعشاب التي قد تساعد ، واكتب عشبًا واطلع على الأمراض والأعراض التي تستخدم ضدها. * تستند جميع المعلومات إلى البحوث العلمية المنشورة